Characterization of Recombinant Toxin rCCK96-104PE38 Targeting Colon Cancer
ZHANG Song,LIU Xi-lin,LI Meng,CHANG Jiang,GAO Shi-qi,HU Pan,LIU Zeng-shan
DOI: https://doi.org/10.13560/j.cnki.biotech.bull.1985.2017.04.032
2017-01-01
Abstract:This work aims to conduct the prokaryotic expression and purification of a novel recombinant toxin rCCK96-104PE38,and to verify the targeted killing effect on colon cancer cells. A reversed cholecystokinin(rCCK96-104)was conjunct to pseudomonas exotoxin(PE38)by gene amplified technology to construct a prokaryotic expression vector. Ni-NTA affinity chromatograph was used for purification. The anti-tumor ability of rCCK96-104PE38 was verified by in vitro cytotoxicity of colon cancer cells and vivo experiment with nude mice model. Results showed that the amplified gene of rCCK96-104PE38 was in correct sequence as designed,i.e.,the active expression was successfully achieved using prokaryotic expression system of pET-28a. The purified recombinant protein induced the apoptosis of colon cancer cells in vitro,and inhibited the tumor growth in nude mice model. Conclusively,it was successful to produce the recombinant toxin rCCK96-104PE38 in high purity and with no tags,the vitro and vivo experiments confirmed that it had inhibitory ability on colon cancer.